LIC MF Healthcare Fund Regular Growth is a Sector - Healthcare mutual fund scheme from LIC Mutual Fund Asset Management Limited. The fund was launched on 28 February 2019 and is managed by Dhaval Sangoi and Sudhanshu Asthana. As of 13 October 2026, the fund has an AUM of ₹99.36 Cr and its latest NAV is ₹32.18. The fund has a Very High Risk risk rating.
The fund allows minimum SIP of ₹200 and lumpsum investment starting from ₹5,000.
The fund primarily invests in Healthcare and Basic Materials and its top holdings include Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Neuland Laboratories Ltd, Torrent Pharmaceuticals Ltd, and Apollo Hospitals Enterprise Ltd. The fund has delivered 7.7% returns over the last 1 year, 19.2% annualised returns over 3 years, 10.2% annualised returns over 5 years, and 16.6% annualised returns since inception.
LIC MF Healthcare Fund Regular Growth may be suitable for investors looking for Sector - Healthcare and who are comfortable with Very High Risk risk.






